4528 — Ono Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapNeutral

Annual cashflow statement for Ono Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Tanshin
Standards:	—	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	105,025	143,532	163,734	59,328	92,654
Depreciation
Non-Cash Items	-19,596	-830	11,403	4,757	901
Unusual Items
Other Non-Cash Items
Changes in Working Capital	-41,321	-543	-82,617	-8,520	5,514
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	61,829	159,610	110,660	82,459	136,821
Capital Expenditures	-12,277	-14,497	-20,829	-7,990	-53,270
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	18,315	-85,762	68,906	-128,795	13,410
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	6,038	-100,259	48,077	-136,785	-39,860
Financing Cash Flow Items	-4	-8	-10	-11	-6
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-60,237	-32,484	-89,848	94,299	-65,493
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	8,066	27,022	70,005	38,425	32,480